Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, Dessinioti C, Feldman SR, Zouboulis CC. Acne vulgaris. Nat Rev Dis Primers. 2015;1:15029. https://doi.org/10.1038/nrdp.2015.29.
Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, et al. Prevalence of most common skin diseases in Europe: a population-based study. J Eur Acad Dermatol Venereol. 2022;36(7):1088–96. https://doi.org/10.1111/jdv.18050.
Article CAS PubMed PubMed Central Google Scholar
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133–61. https://doi.org/10.1016/s0140-6736(24)00757-8.
Zhu Z, Zhong X, Luo Z, Liu M, Zhang H, Zheng H, et al. Global, regional, and national burdens of acne vulgaris in adolescents and young adults aged 10–24 years from 1990 to 2021: a trend analysis. Br J Dermatol. 2025;192(2):228–37. https://doi.org/10.1093/bjd/ljae352.
Layton AM, Thiboutot D, Tan J. Reviewing the global burden of acne: how could we improve care to reduce the burden? Br J Dermatol. 2021;184(2):219–25. https://doi.org/10.1111/bjd.19477.
Article CAS PubMed Google Scholar
United States Food and Drug Administration. Patient-reported outcome measures: use in medical product development to support labeling claims. 2009. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims. Accessed 3 Feb 2025.
Nast A, Dréno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, et al. European evidence-based (S3) guideline for the treatment of acne—update 2016—short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261–8. https://doi.org/10.1111/jdv.13776.
Article CAS PubMed Google Scholar
Layton AM, Eady EA, Thiboutot DM, Tan J, Acne Core Outcomes Research Network (ACORN) Outcomes Identification Group. Identifying what to measure in acne clinical trials: first steps towards development of a core outcome set. J Investig Dermatol. 2017;137(8):1784–6. https://doi.org/10.1016/j.jid.2017.04.017.
Article CAS PubMed Google Scholar
Tan J, Thiboutot D, Layton A, Miklas M. Developing a core outcome set for acne clinical trials: towards standardization and harmonization. In: Suh DH, editor. Acne: current concepts and management. Springer International Publishing: Cham; 2021. p. 25–33. https://doi.org/10.1007/978-3-030-68996-4_3.
Chernyshov PV, Zouboulis CC, Tomas-Aragones L, Jemec GB, Manolache L, Tzellos T, et al. Quality of life measurement in acne. Position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa. J Eur Acad Dermatol Venereol. 2018;32(2):194–208. https://doi.org/10.1111/jdv.14585.
Article CAS PubMed Google Scholar
Smith H, Layton AM, Thiboutot D, Smith A, Whitehouse H, Ghumra W, et al. Identifying the impacts of acne and the use of questionnaires to detect these impacts: a systematic literature review. Am J Clin Dermatol. 2021;22(2):159–71. https://doi.org/10.1007/s40257-020-00564-6.
Hopkins ZH, Thiboutot D, Homsi HA, Perez-Chada LM, Barbieri JS. Patient-reported outcome measures for health-related quality of life in patients with acne vulgaris: a systematic review of measure development and measurement properties. JAMA Dermatol. 2022;158(8):900–11. https://doi.org/10.1001/jamadermatol.2022.2260.
Article PubMed PubMed Central Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.
Article PubMed PubMed Central Google Scholar
Finlay AY, Khan GK. Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–6. https://doi.org/10.1111/j.1365-2230.1994.tb01167.x.
Article CAS PubMed Google Scholar
Joanna Briggs Institute. JBI Critical Appraisal Tools. 2025. https://jbi.global/critical-appraisal-tools. Accessed 10 Jan 2025.
Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. JBI manual for evidence synthesis. Chapter 7: systematic reviews of etiology and risk. 2020. https://synthesismanual.jbi.global/. Accessed 13 Nov 2024.
Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18(10):2127–33. https://doi.org/10.11124/jbisrir-d-19-00099.
Barker TH, Habibi N, Aromataris E, Stone JC, Leonardi-Bee J, Sears K, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evid Synth. 2024;22(3):378–88. https://doi.org/10.11124/jbies-23-00268.
Barker TH, Stone JC, Sears K, Klugar M, Tufanaru C, Leonardi-Bee J, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid Synth. 2023;21(3):494–506. https://doi.org/10.11124/jbies-22-00430.
Lockwood C, Munn Z, Porritt K. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. Int J Evid Based Healthc. 2015;13(3):179–87. https://doi.org/10.1097/xeb.0000000000000062.
Goplen CM, Verbeek W, Kang SH, Jones CA, Voaklander DC, Churchill TA, et al. Preoperative opioid use is associated with worse patient outcomes after total joint arthroplasty: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2019;20(1):234. https://doi.org/10.1186/s12891-019-2619-8.
Article PubMed PubMed Central Google Scholar
Mahmud S, Hossain MF, Muyeed A, Nazneen S, Haque MA, Mazumder H, et al. Risk assessment and clinical implications of COVID-19 in multiple myeloma patients: a systematic review and meta-analysis. PLoS ONE. 2024;19(9):e0308463. https://doi.org/10.1371/journal.pone.0308463.
Article CAS PubMed PubMed Central Google Scholar
Still A, Hale L, Alam S, Morris ME, Jayakaran P. Relationships between physical activities performed under free-living conditions and non-motor symptoms in people with Parkinson’s: a systematic review and meta-analysis. Clin Rehabil. 2024;38(11):1534–51. https://doi.org/10.1177/02692155241272967.
Article PubMed PubMed Central Google Scholar
Bae IH, Kwak JH, Na CH, Kim MS, Shin BS, Choi H. A comprehensive review of the acne grading scale in 2023. Ann Dermatol. 2024;36(2):65–73. https://doi.org/10.5021/ad.23.094.
Article PubMed PubMed Central Google Scholar
Altunay IK, Özkur E, Dalgard FJ, Gieler U, Tomas Aragones L, Lien L, et al. Psychosocial aspects of adult acne: data from 13 European countries. Acta Derm Venereol. 2020;100(4):1–6. https://doi.org/10.2340/00015555-3409.
Andrese E, Vata D, Porumb V, Martu C, Statescu L, Solovastru LG. New complex (α hydroxy acids, β hydroxy acids, niacinamide and glycerin) for local treatment of acne vulgaris. Rev Chim. 2016;67(8):1591–3.
Chernyshov PV, Petrenko A, Kopylova V. What health-related quality of life factors influence the decision of patients with acne to visit a dermatologist? J Clin Aesthet Dermatol. 2018;11(7):21–5.
PubMed PubMed Central Google Scholar
Chilicka K, Maj J, Panaszek B. General quality of life of patients with acne vulgaris before and after performing selected cosmetological treatments. Patient Prefer Adherence. 2017;11:1357–61. https://doi.org/10.2147/ppa.S131184.
Article PubMed PubMed Central Google Scholar
Chilicka K, Rogowska AM, Szyguła R, Taradaj J. Examining quality of life after treatment with azelaic and pyruvic acid peels in women with acne vulgaris. Clin Cosmet Investig Dermatol. 2020;13:469–77. https://doi.org/10.2147/ccid.S262691.
Article CAS PubMed PubMed Central Google Scholar
Dashko MO, Syzon OO, Chaplyk-Chyzho IO, Turkevych SA. Pathogenetic peculiarities of neuroendocrine and metabolic disorders in patients with acne associated with chronic stress. Wiad Lek. 2019;72(5 cz 2):997–1001.
Davern J, O’Donnell AT. Stigma predicts health-related quality of life impairment, psychological distress, and somatic symptoms in acne sufferers. PLoS ONE. 2018;13(9):e0205009. https://doi.org/10.1371/journal.pone.0205009.
Comments (0)